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Methodology: How does the Belgian Obstetric 
Surveillance System work? 
Institute 
The Belgian Obstetric Surveillance System, briefly 
B.OSS, is initiated with support of the College of 
Physicians for Mother and Newborn, a consultative 
body of the Federal Public Service of Health. B.OSS 
is endorsed by the two professional associations for 
OB-GYNs (Vlaamse Vereniging voor Obstetrie 
en Gynecologie (VVOG) and Groupement des 
Gynécologues Obstétriciens de Langue Française 
de Belgique (GGOLFB)), and by the perinatal 
registries SPE and  CEpiP. The College operates as 
the steering committee of B.OSS. In 2017, a formal 
scientific board is constituted with representatives 
of SPE, CEpiP, the Belgian Health Care Knowledge 
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Abstract
Background: In 2011 the Belgian Obstetric Surveillance System (B.OSS) was set up to monitor severe maternal 
morbidity in Belgium. 
Aim: The aim of B.OSS is to get an accurate picture of the obstetric complications under investigation and secondly, 
to improve the quality and safety of obstetric care in Belgium by practical recommendations based on the results. 
Methodology: Data are obtained through prospective active collection of cases by a monthly call according to the 
principle of nothing-to-report, along with data collection forms that confirm the diagnosis and gather detailed 
information. Data-collection occurs web-based since August 2013 through www.b-oss.be. 
Results: B.OSS achieves excellent participation rates and response rates. The results of the first registration round 
are gradually brought out by means of scientific publications and presentations, biennial reports, newsletters 
and the website. The international comparison of results within the International Network of Obstetric Survey 
Systems (INOSS) gives important added value. No alternative mandatory data sources are appropriate to check 
for underreporting. 
Conclusions: B.OSS is successful in monitoring severe maternal morbidity thanks to the willingness of the Belgian 
OB-GYNs. The results of the first studies suggest the need to develop nationally adopted guidelines. Furthermore, 
the results invite to critically evaluate the current organisation of obstetric health care in Belgium. B.OSS aims 
to monitor the impact on patient safety in future surveys, when guidelines and recommendations are put into 
practice.   
Key words: Severe maternal morbidity, maternal near miss, quality of care, obstetric health care, obstetric 
surveillance system, population-based. 
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and processed into operational SPSS data files. Data-
analysis is performed using IBM SPSS statistics 
(IBM Corp. Released 2013. IBM SPSS Statistics for 
Windows, Version 22.0. Armonk, NY: IBM Corp), 
EpiTools epidemiological calculators (Sergeant, 
ESG, 2017. Epitools epidemiological calculators. 
Ausvet Pty Ltd. Available at: http://epitools.ausvet.
com.au) and MedCalc for Windows, version 15.0 
Software (MedCalc Software, Ostend, Belgium). 
The prevalence of the obstetric events targeted 
is estimated using as denominator the total number 
of deliveries in Belgium during the survey period, 
corrected for the maternity units that did not 
participate. Reference data are obtained from the 
perinatal registries (SPE and CEpiP) when available. 
Ethics approval 
The B.OSS methodology was approved by the 
Medical Ethics Committee of Ghent University 
Hospital (EC UZG 2012/734; B670201215359) 
and by the Medical Ethics Committee of the Erasme 
University Hospital, Brussels (EC ULB 2012/111; 
B406201213660) at the beginning. The Medical 
Ethics Committee of the Ghent University Hospital 
became Central Ethics Committee in 2015 (EC 
UZG 2015/1470; B670201526875). The women 
eligible for inclusion are informed by their OB-
GYN and offered an information letter enabling 
them to opt-out. Confidentiality is guaranteed for 
mother, provider and hospital. Person-identifiable 
information is eliminated from data-analysis. 
 
Results: What is the output of the Belgian 
Obstetric Surveillance System? 
Participation rate and response rate 
At start, 110 of 113 Belgian maternity units (97.3 %) 
formally agreed to participate in B.OSS; the three 
Centre (KCE), the Scientific Institute of Public 
Health (WIV-ISP) and the College. Daily reporting 
and data collection tasks are carried out by two 
cooperating teams: one in Flanders, another in 
Brussels and Wallonia.  
Data collection 
B.OSS has adopted the methodology for case 
reporting developed by the UK Obstetric 
Surveillance System (UKOSS)(Knight et al., 2005). 
An appointed contact person (OB-GYN or senior 
midwife) in each participating maternity unit is 
invited by monthly mailing to report a selected 
number of rare obstetric complications that occurred 
in the preceding month or alternatively to state that 
there was ‘nothing to report’, as is mostly the case. 
In the event of a case being reported, the contact 
person is asked to complete an extensive data 
collection form. In case of incomplete reporting, the 
contact person is encouraged repeatedly by email 
and phone to provide the missing data. 
Website www.b-oss.be 
Initially, the data of the reported cases were 
obtained through use of a standardised form, filled 
out electronically or on hard copy. Web-based data-
collection was gradually introduced following the 
launch of the B.OSS website (www.b-oss.be) in 
August 2013, facilitating monthly reporting and 
completion of data collection forms online. Monthly 
emails calling to report for the previous month are 
generated automatically, with reminders for missing 
reporting forms and incomplete data collection 
forms. Restricted access to the website is provided 
to the appointed contact person, one per maternity 
unit, via a personal login. They have access to the 
reporting forms and data collection forms of their 
maternity unit. Data protection is secured by the 
use of anonymous hash codes, replacing person-
identifiable information such as the woman’s name, 
date of birth or hospital number. 
Registered variables 
The data collection forms seek information on 
maternal characteristics, medical, surgical and 
obstetric history, details of the index pregnancy, 
details of the delivery, the circumstances of the 
adverse event, its management and the outcome 
for mother and neonate. The data are retrieved in 
retrospect from the woman’s case notes. 
Data analysis 
The collected data are coded and exported as 
comma-separated values (csv) files, then cleaned 
Figure 1: The continuum from uncomplicated pregnancy to 
maternal mortality. Adapted from The Pyramid of Disease. 
PowerPoint Presentation. Introduction to UKOSS. Retrieved 
from https://www.npeu.ox.ac.uk/ukoss.  and The spectrum of 
morbidity: from noncomplicated pregnancies to maternal death. 
Say et al., (2009).
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the previous two years, is distributed to all OB-GYNs 
and maternity units. The website (http://www.b-
oss.be) provides information on the background 
and methodology of B.OSS. Study protocols, data 
collection forms, the patient information letter, 
scientific publications and presentations of B.OSS-
results are freely accessible. The contact persons 
have restricted access to the newsletters, biennial 
reports and a continuously updated response rate. 
Validation of data 
Despite monthly emails and frequent reminders, 
underreporting of cases cannot be excluded. 
Underreporting is attributed to the non-mandatory 
participation of busy clinicians and to the case’s 
nature: severe maternal complications and near miss 
cases, maybe evoked by some degree of concern on 
the quality of care. 
We consulted two national data sources, 
collecting medical data on a mandatory basis, that 
could possibly serve as a control for underreporting 
for the data recorded by B.OSS. Firstly, the Belgian 
hospital discharge register (Minimale Ziekenhuis 
Gegevens (MZG), Résumé Hospitalier Minimum 
(RHM)), which used the International Classification 
of Diseases,
Ninth Revision, Clinical Modification (ICD-
9-CM) (CDC, 2013) codes up to January 2015. 
From this data source we derived the total number 
of peripartum hysterectomy, eclampsia and uterine 
rupture, indicated by clinicians from January 
until December 2012. The number of arterial 
embolisations derived from the hospital discharge 
register was not accurate, due to the lack of a specific 
remaining maternity units have been recruited since. 
The number of maternity units dropped through the 
years as a result of merging and closure, with 106 
of 107 (99%) participating in January 2017. B.OSS 
achieved an excellent response rate (the number 
of monthly reporting forms returned) at start in 
2012-2013 (98.9%), which slightly dropped in the 
following years (Fig. 2). 
Completed and ongoing studies 
B.OSS completed a two-year study of uterine 
rupture (2012-2013) and peripartum hysterectomy 
and/or arterial embolisation of the uterine arteries 
(2012-2013) and a three-year study of eclampsia 
(2012-2014). Currently B.OSS is conducting a 
four-year study of antenatal pulmonary embolism 
(APE) (2015-2018) and is participating in the 
INOSS international studies of spontaneous 
haemoperitoneum in pregnancy (SHiP) (2015-2017) 
and anaphylaxis in pregnancy (2016-2018). 
Publications, newsletters, biennial reports and 
website 
The results of the first registration round are 
brought out gradually. The prevalence, risk 
factors, management and outcome of the obstetric 
complications under investigation are communicated 
towards obstetric and other health care providers by 
means of scientific publications and presentations.
(Vandenberghe et al., 2016; 2017) A newsletter is 
sent out every six months, providing intermediate 
results and practical information, besides asking for 
feedback and ideas for improvement. A biennial 
report summarising the achievements of B.OSS in 
Figure 2: Yearly response rate of the Belgian Obstetric Surveillance System in percentage.
Percentage OF rePOrting FOr ms returned
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Insurance Funds Agency (het InterMutualistisch 
Agentschap (IMA), l’Agence InterMutualiste 
(AIM))(IMA-AIM, 2017). The IMA-AIM records 
administrative and billing data of all Belgian 
inhabitants affiliated to the seven Belgian Health 
Insurance funds. The database of IMA-AIM 
includes information of every medical act that was 
carried out and reimbursed in Belgium based on 
a specific nomenclature code, such as the timing 
and location of the medical act and (coded) patient 
data. From this data source we derived the total 
number of hysterectomies and arterial embolisations 
carried out from January 2012 until December 
2013 within 4 weeks following a vaginal birth or 
caesarean section. In Table II is shown that the 
number of peripartum hysterectomies recorded by 
IMA-AIM was almost equal, while the number of 
arterial embolisations largely exceeded the number 
reported by B.OSS. Possible explanations for this 
discrepancy are the accuracy of the nomenclature 
code, which is not specific for embolisation of the 
uterine arteries, and the hypothesis that in some cases 
embolisation catheters were placed prophylactically 
ICD-9-cm code indicating the embolisation of the 
uterine arteries. As shown in Table I, all numbers 
from the hospital discharge register exceeded the 
numbers derived by B.OSS during the same period, 
even twice (eclampsia) or three times (uterine 
rupture). This is in line with the findings of true 
validation studies, such as a study from Denmark 
(Thisted et al., 2014) in which only 60.4% of the 
women registered with an ICD-10 code for uterine 
rupture during labour actually had a uterine rupture. 
Likewise, a validity study from the United States 
demonstrated a high positive predictive value (PPV) 
for ICD-9-cm codes indicating procedures, such as 
hysterectomy (PPV 100%, 95% CI 86-100%) and a 
low PPV for ICD-9-cm codes indicating conditions 
that require the interpretation of clinical information, 
such as eclampsia (PPV 55%, 33-76%) (Sigakis et 
al., 2016). We trust that the methodology of the 
obstetric surveillance system, through monthly 
reporting and detailed data collection forms, should 
be more precise than the hospital discharge register. 
The second data source theoretically allowing 
control for underreporting is the Inter Health 













Discharge Register (MZG, 
RHM) 57 24 54 116 
 
B.OSS 
 44 53 24 41 
* ICD-9-CM codes: 68.31,68.39, 68.41, 68.49, 68.51,68.59, 68.61, 68.69, 68.71, 68.79, 68.9 
§ ICD-9-CM codes: 38.86, 39.79. The codes 68.24 and 68.25: uterine artery embolization (UAE) with coils and without coils, 
were not yet available.  
$ ICD-9-CM codes : 642.6x  
# ICD-9-CM codes : 665.0, 665.1  
Severe obstetric complication Peripartum hysterectomy  Peripartum embolisation 





 *IMA-AIM records billing data of Belgian inhabitants affiliated to the seven Belgian Health Insurance funds, using 
nomenclature codes.  
Table I. —Number of hospital stays for pregnancy, delivery or abortion, with report of severe obstetric complication in 2012 by 
the Belgian Hospital Discharge Register; compared to the number registered by the Belgian Obstetric Surveillance System (B.OSS).  
Table II. — Number of peripartum hysterectomies and peripartum arterial embolisations in 2012-2013 recorded by IMA-AIM; 
compared to the number registered by the Belgian Obstetric Surveillance System (B.OSS).  
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criteria (Schaap et al., 2014) is 1.6 (95% CI 1.2-2.1) 
per 10,000 deliveries in Belgium, which is very low 
compared to the prevalence in the UK (2.7 (95% CI 
2.4-3.2) per 10,000 deliveries) (Knight, 2007) and 
the Netherlands (5.4 (95% CI 4.6-6.2) per 10,000 
deliveries) (Schaap et al., 2014).
Recommendations based on B.OSS results
  
The B.OSS findings give rise to practical 
recommendations: which changes should be made 
in clinical practice to improve the quality and safety 
of obstetric care? 
Based on the study of uterine rupture, 
(Vandenberghe et al., 2016) we believe that obstetric 
care in Belgium would benefit from a nationally 
adopted guideline on trial of labour after caesarean 
section (TOLAC). This guideline should result 
from the comparison and fusion of the existing 
international guidelines (SOGC, 2005; Sentilhes 
et al., 2013; RCOG, 2015; ACOG, 2017) and 
have the consent of the professional associations 
for OB-GYNs, the professional associations for 
midwives and the College of Physicians for Mother 
and Newborn. The guideline should be developed 
to promote safe TOLAC in appropriate candidates 
on one hand, in order to enhance the low current 
TOLAC rate in Belgium. On the other hand, the 
guideline should prevent unsafe procedures, which 
have been observed among the uterine rupture cases 
in the B.OSS study. Furthermore, the guideline 
should include recommendations on the mode 
of delivery in women with other uterine surgical 
procedures (such as myomectomy, hysteroscopic 
resection of a uterine septum or salpingectomy), 
in whom a management similar to women with 
previous caesarean section is justified. A follow-up 
registration of uterine rupture by B.OSS should 
be planned over time, to monitor the effect of and 
compliance with the national guideline. 
Based on the study of peripartum hysterectomy 
and arterial embolisation, (Vandenberghe et al., 
2017) we believe that the management of obstetric 
haemorrhage in Belgium could be further improved 
if all women with abnormal placentation were 
managed in a tertiary referral centre. Therefore, 
we need to enhance the awareness of risk factors 
for abnormal invasive placenta (AIP) on the part of 
clinicians in order to improve the identification of 
women at risk and increase the antenatal transfer to 
tertiary referral centres in case of suspicion. This can 
be achieved by, besides the development of a new 
national guideline, the propagation of the B.OSS 
publication accompanied by clear instructions and 
ultrasound criteria for AIP, through the websites of 
B.OSS and the professional associations for OB-
before planned caesarean sections with expected 
high risk of obstetric haemorrhage while the actual 
arterial embolisation did not need to be carried out. 
This data-source could not provide data of uterine 
ruptures or eclampsia, because those complications 
do not involve a specific medical act with traceable 
nomenclature code. Hence, the IMA-AIM database 
may only be of use to validate surveys of procedures 
indicative of severe maternal morbidity. 
 
International comparison and benchmarking
The use of similar methods and data collection forms 
based on the UKOSS, enables the comparison of the 
Belgian data with the results of studies performed 
by obstetric surveillance systems in other countries. 
The international comparison of prevalences, risk 
factors, management and outcome adds important 
value on top of the conclusions that can be made 
based on national data. 
Within the INOSS network, we conducted an 
international comparison study of uterine rupture 
between nine countries, resulting in the largest 
prospective population-based report of uterine 
rupture in high-income countries (unpublished data, 
paper submitted October 2017). This study reports 
a prevalence of uterine rupture in women with 
previous caesarean section of 22 (95% CI 2124) 
per 10,000 deliveries, ranging from 8 (95% CI 
6-11) to 68 (95% CI 56-83) per 10,000 deliveries. 
This wide range in prevalence between countries 
appears to be, amongst others, a consequence of 
the range in trial of labour after caesarean section 
(TOLAC) rates between countries (from 47% to 
72%). Benchmarking population-based TOLAC 
rates opposed to uterine rupture rates reveals that 
countries with high TOLAC rates pay a slightly 
higher price in uterine ruptures per TOLAC. This 
international comparison study suggests a need to 
critically appraise TOLAC policies in each country: 
first, the selection of appropriate candidates and 
second, the management of labour in women 
who decided to undergo TOLAC. With regard 
to Belgium, the prevalence of uterine rupture in 
women with previous caesarean section (21 (95% CI 
16-27) per 10,000 deliveries) is in the lower-middle 
of prevalences, while the TOLAC rate (percentage 
of women with previous caesarean section who 
underwent TOLAC) is the second lowest within this 
INOSS-group (47.2%). 
Furthermore, Belgium has the second lowest 
peripartum hysterectomy rate (3.1 (95% CI 2.6-4.0) 
per 10,000 deliveries) in an international comparison 
study between ten INOSS countries (range 3.0 to 
7.8 per 10,000 deliveries) (unpublished data). And 
the prevalence of eclampsia applying the UKOSS 
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mandatory by the government. 
Thanks to its methodology, that is the prospective 
collection of cases through an active search on 
a monthly basis according to the principle of 
nothing-to-report, the number of missed cases 
(false negatives) can be reduced to a great extent. 
Besides, the number of false positives is limited to 
a minimum thanks to the detailed data collection 
forms that confirm the diagnosis. However, there 
is currently no appropriate way to check the data 
of B.OSS for completeness and correctness. The 
validity of B.OSS data could be further improved by 
involving more than one clinician per maternity unit, 
such as a senior midwife, an obstetric anaesthesist 
or an intensive care specialist. This would follow 
the lead of the UKOSS, where four clinicians are 
nominated in each hospital (Knight et al., 2005). 
The launch of the B.OSS website (http://www.b-
oss.be) substantially reduced the workload of the 
research team and contact persons by enabling web-
based data collection. For example, the monthly 
reporting is now easily done in three clicks by 
an email link. However, the commitment to the 
B.OSS project does involve additional work to 
contact persons on top of their clinical practice. 
Moreover, clinicians are regularly approached 
to participate in all kind of surveys. To further 
improve the workload, attention must be paid 
to keep data collection forms of future surveys 
more concise and clear. Furthermore, future data 
collections will adhere to the INOSS Core Dataset 
(ICoD), a standardized minimum dataset developed 
by the International Network of Obstetric Survey 
System, to enhance the comparison of data between 
different countries. Over time, it would be most 
expedient if B.OSS could join the federal project 
Healthdata.be (WIV-ISP), a platform developed 
to reduce the administrative burden of clinicians. 
The Healthdata-platform aims to standardise and 
harmonise the registration and storage of health 
data, while absolute confidentiality is guaranteed. It 
enables to gather health data in a standardised way 
from different health care institutions and health 
care providers using many different medical record 
systems, by implementing a specifically developed 
software program. Since start in 2014, they 
succeeded to successfully integrate 42 registries 
into the platform. We await further development and 
results of Healthdata, to assess whether the B.OSS 
data collection could be (partially) covered by this 
platform. 
 
Addition of audit studies 
The B.OSS surveys give an overall picture of the 
severe obstetric complications under surveillance, 
GYNs and through presentations on regional and 
national conferences. More influential would be a 
restructuring of (obstetric) health care in Belgium 
by the government, making referral to tertiary 
referral centres obviously and compulsory in case 
of certain conditions, such as AIP. A follow-up 
registration by B.OSS should include all women 
with massive obstetric haemorrhage, using the 
INOSS international consensus definition,(Schaap 
et al., 2017) and all women successfully managed 
with other second-line measures (such as intra-
uterine balloon tamponade), to get the overall 
picture of postpartum haemorrhage in Belgium. 
Furthermore, a case-by-case in-depth analysis would 
be interesting to reveal whether the hysterectomies 
and arterial embolisations performed in this study 
were appropriate or preventable. Based on the 
current findings, we hypothesise that hysterectomies 
may be performed more easily in smaller maternity 
units, while there may be an overuse of arterial 
embolisations when this service is easily accessible, 
without first resorting to second-line measures. 
Based on the study of eclampsia, we believe that 
there is scope for improvement by increasing the 
awareness of health care providers, mainly general 
practitioners and emergency room doctors besides 
OB-GYNs and midwives, of the use of magnesium 
sulphate as the first choice treatment in case of an 
eclamptic fit. In current B.OSS study magnesium 
sulphate was administered as first treatment in only 
54% of the women. This calls for another national 
guideline. 
Discussion: How can we further improve the 
Belgian Obstetric Surveillance System? 
Strengths and limitations 
Although relying on the willingness of busy 
clinicians, B.OSS achieves an excellent participation 
rate and response rate. The success of B.OSS 
demonstrates the hunger for information on severe 
maternal morbidity on a national basis. Rates 
gradually dropped in the latest years however, 
blamed partly on the extremely rare conditions 
currently under investigation. To further motivate 
clinicians and boost the response rate, we suggest 
several action points. Firstly, starting new studies 
that investigate more common conditions that 
are relevant for every obstetrician. Secondly, 
proclaiming the results of the first B.OSS studies in 
presentations and publications and proclaiming the 
impact on quality of care, when recommendations 
have been implemented over time. Thirdly, 
rewarding the maternity units that register in a pay-
for-quality project or making the B.OSS registration 
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Belgium. B.OSS aims to monitor the impact on 
patient safety in future surveys, when guidelines and 
recommendations are put into practice.  
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